(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
| Sales | 15007.00 | 9325.80 | 60.92 | 44941.10 | 33293.80 | 34.98 | 47070.40 | 47687.20 | -1.29 |
| Other Income | 29.80 | 71.90 | -58.55 | 100.10 | 192.60 | -48.03 | 215.50 | 273.20 | -21.12 |
| PBIDT | 3880.80 | 2226.10 | 74.33 | 12393.30 | 9315.50 | 33.04 | 13067.50 | 15371.90 | -14.99 |
| Interest | 392.60 | 209.40 | 87.49 | 1046.70 | 665.70 | 57.23 | 958.60 | 659.20 | 45.42 |
| PBDT | 3488.20 | 2016.70 | 72.97 | 11346.60 | 8649.80 | 31.18 | 12108.90 | 14712.70 | -17.70 |
| Depreciation | 784.80 | 597.20 | 31.41 | 2200.30 | 1745.40 | 26.06 | 2354.80 | 1966.40 | 19.75 |
| PBT | 2703.40 | 1419.50 | 90.45 | 9146.30 | 6904.40 | 32.47 | 9754.10 | 12746.30 | -23.48 |
| TAX | 712.90 | 327.90 | 117.41 | 2565.30 | 1615.70 | 58.77 | 2253.20 | 3185.20 | -29.26 |
| Deferred Tax | 0.90 | -48.70 | -101.85 | -68.10 | 66.00 | -203.18 | -61.00 | -164.60 | -62.94 |
| PAT | 1990.50 | 1091.60 | 82.35 | 6581.00 | 5288.70 | 24.44 | 7500.90 | 9561.10 | -21.55 |
| Equity | 1077.30 | 1074.70 | 0.24 | 1077.30 | 1074.70 | 0.24 | 1074.70 | 1073.20 | 0.14 |
| PBIDTM(%) | 25.86 | 23.87 | 8.34 | 27.58 | 27.98 | -1.44 | 27.76 | 32.23 | -13.88 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1931.50 |
| Dr. Reddys Labs. | 1247.30 |
| Cipla | 1442.85 |
| Zydus Lifesciences | 1149.65 |
| Lupin | 2492.90 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: